01 60Smart & Biggar
02 38Smart & Biggar LLP
01 102426921
02 102429496
03 62511619
04 62526562
05 42534997
06 42543242
07 102688915
08 102688934
09 102689051
10 102689052
11 102700314
12 62713466
13 22869889
01 38ARIPIPRAZOLE
02 60Aripiprazole
01 36POWDER FOR SUSPENSION
02 2SUSPENSION (EXTENDED-RELEASE)
03 60Tablet
01 21933-04-23
02 202022-01-29
03 562022-09-25
04 62023-12-25
05 62024-05-19
06 42024-07-29
07 42024-10-18
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-01
Brand Name : ABILIFY
Patent Number : 2688915
Filing Date : 2002-09-25
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-01
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-15
Brand Name : ABILIFY
Patent Number : 2689052
Filing Date : 2002-09-25
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-15
Patent Expiration Date : 2022-09-25
Date Granted : 2011-03-08
Brand Name : ABILIFY
Patent Number : 2689051
Filing Date : 2002-09-25
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-25
Date Granted : 2011-03-08
Patent Expiration Date : 2022-01-29
Date Granted : 2012-04-24
Brand Name : ABILIFY
Patent Number : 2700314
Filing Date : 2002-01-29
Strength per Unit : 2 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-01-29
Date Granted : 2012-04-24
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-15
Brand Name : ABILIFY
Patent Number : 2689052
Filing Date : 2002-09-25
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-15
Patent Expiration Date : 2022-09-25
Date Granted : 2011-03-08
Brand Name : ABILIFY
Patent Number : 2689051
Filing Date : 2002-09-25
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-25
Date Granted : 2011-03-08
Patent Expiration Date : 2022-01-29
Date Granted : 2012-04-24
Brand Name : ABILIFY
Patent Number : 2700314
Filing Date : 2002-01-29
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-01-29
Date Granted : 2012-04-24
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-15
Brand Name : ABILIFY
Patent Number : 2689052
Filing Date : 2002-09-25
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-25
Date Granted : 2011-02-15
Patent Expiration Date : 2022-09-25
Date Granted : 2011-03-08
Brand Name : ABILIFY
Patent Number : 2689051
Filing Date : 2002-09-25
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-09-25
Date Granted : 2011-03-08
Patent Expiration Date : 2022-01-29
Date Granted : 2012-04-24
Brand Name : ABILIFY
Patent Number : 2700314
Filing Date : 2002-01-29
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-01-29
Date Granted : 2012-04-24
